Megan S. Farris

ORCID: 0000-0003-0640-9512
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Schizophrenia research and treatment
  • Cancer survivorship and care
  • Physical Activity and Health
  • Bipolar Disorder and Treatment
  • Cancer Risks and Factors
  • Lipoproteins and Cardiovascular Health
  • Health Systems, Economic Evaluations, Quality of Life
  • Child and Adolescent Psychosocial and Emotional Development
  • Childhood Cancer Survivors' Quality of Life
  • Multiple Myeloma Research and Treatments
  • Psychosomatic Disorders and Their Treatments
  • Pancreatic and Hepatic Oncology Research
  • Attention Deficit Hyperactivity Disorder
  • COVID-19 and healthcare impacts
  • Ovarian cancer diagnosis and treatment
  • Global Cancer Incidence and Screening
  • Mental Health Treatment and Access
  • Mental Health and Psychiatry
  • Obesity, Physical Activity, Diet
  • Breast Lesions and Carcinomas
  • Adolescent and Pediatric Healthcare
  • Cardiovascular and exercise physiology
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Nutrition and Health in Aging
  • Prostate Cancer Diagnosis and Treatment

University of Calgary
2015-2023

Amgen (United States)
2020

Calgary Laboratory Services
2020

Health Economics and Outcomes Research (United Kingdom)
2018-2019

Newbury College
2019

Alberta Health Services
2015-2018

Novartis (Australia)
2018

Sapienza University of Rome
2001

Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of morbidity and mortality worldwide. Data from Canadian populations regarding the burden ASCVD are limited. Therefore, we describe 5-year period prevalence subsequent major adverse event (MACE) outcomes among patients with in Alberta, Canada.A retrospective, observational study was conducted by linking provincial health services data, vital statistics, pharmaceutical dispenses data. Five-year clinical captured between 2011...

10.1002/clc.23732 article EN cc-by Clinical Cardiology 2021-09-29

This prospective study examined the associations between postdiagnosis physical activity and change from prediagnosis with quality of life (QoL) in prostate cancer survivors.Prostate survivors (N = 830) who participated a case-control invasive stage ≥II disease were followed up to 2007 capture QoL outcomes. At baseline three time points (2000-2007), interviews/questionnaires used collect data on activity, general measured by SF-36, other treatment/lifestyle factors. Multivariable linear...

10.1158/1055-9965.epi-16-0465 article EN Cancer Epidemiology Biomarkers & Prevention 2016-09-28

Evidence regarding the role of anthropometrics in prostate cancer survival is inconsistent. We examined associations between anthropometric measures and outcomes. Men diagnosed with (n=987) were recruited into a population-based case–control study 1997 2000 then prospective cohort 2002 where measurements (weight, height, body mass index, waist circumference, waist-hip ratio) taken participants followed up to 19 years for Cox proportional hazards used examine these associations. Survival...

10.1038/bjc.2017.440 article EN cc-by-nc-sa British Journal of Cancer 2017-12-12

Alcohol consumption has been declared a Group 1 carcinogen by the International Agency for Research on Cancer (IARC) and is potential risk factor several types of cancer mortality. However, evidence an association with prostate survival remains inconsistent. We examined how alcohol post‐diagnosis was associated after diagnosis. Men diagnosed ( n = 829) in Alberta, Canada between years 1997 2000 were recruited into population‐based case–control study then followed up to 19 outcomes. Pre‐...

10.1002/ijc.31307 article EN International Journal of Cancer 2018-02-13

Few studies have examined recreational physical activity (RPA) after participating in a structured exercise intervention. More specifically, little is known about the long-term effects of interventions post-menopausal women. This study had two objectives: 1) To compare RPA postmenopausal women group and control 12 months end Alberta Physical Activity Breast Cancer Prevention (ALPHA) Trial; 2) apply Theory Planned Behaviour (TPB) to identify predictors post-intervention among group....

10.1186/s12966-015-0219-z article EN cc-by International Journal of Behavioral Nutrition and Physical Activity 2015-05-04

To our knowledge, the Alberta Moving Beyond Breast Cancer (AMBER) Study is first and only prospective cohort study of breast cancer survivors that includes objectively-measured physical activity (PA), sedentary behavior, health-related fitness (HRF), biologic mechanisms focused on understanding outcomes. The purpose present was to report feasibility recruitment, baseline measurement completion, representativeness 500 participants. AMBER enrolling newly diagnosed stage I (≥T1c) IIIc in...

10.1186/s12885-016-2534-4 article EN cc-by BMC Cancer 2016-07-14

Physical activity has emerged as an important lifestyle factor for primary prevention of numerous diseases, including postmenopausal breast cancer. No study to date assessed the acute and long-term effects year-long aerobic exercise programs differing in prescribed volume on physical sedentary time women. Therefore, we aimed examine two moderate-vigorous intensity doses total, light times, women during intervention one year later. The Breast Cancer Exercise Trial Alberta (BETA) was a...

10.1186/s12966-018-0659-3 article EN cc-by International Journal of Behavioral Nutrition and Physical Activity 2018-03-21

A high proportion of Canadian patients with acute myocardial infarction (AMI) do not achieve the threshold low-density lipoprotein cholesterol (LDL-C) levels recommended by Cardiovascular Society in 2021. This increases risk subsequent atherosclerotic cardiovascular disease (ASCVD) events. Here, we assess LDL-C and achievement among lipid-lowering therapies (LLT) received post-AMI. retrospective cohort study identified AMI between 2015 2019 was conducted using administrative health databases...

10.1007/s40119-022-00300-7 article EN cc-by-nc Cardiology and Therapy 2023-01-19

Abstract Objective The objective of this study was to identify a sample youth in distinct stages risk for the development serious mental illness (SMI) according published clinical staging model and follow longitudinally determine changes over time. This article reports 6‐ 12‐month follow‐up cohort. Methods recruited 243 youth, ages 12 25. included (a) 42 healthy controls, (b) 41 nonhelpseeking individuals with no but some SMI, example, having first‐degree relative an SMI (stage 0), (c) 53...

10.1111/eip.13062 article EN Early Intervention in Psychiatry 2020-10-09
Coming Soon ...